CEO Update - 1 July 2024

UK General Election


I will watch the General Election this Thursday with great interest, like the rest of the country, and update you on the new ministers and members of Parliament next week. You can access the policy backgrounds of the main parties and view our webinar on what the campaign has taught us about what our sector should expect from the new parliament and government. It was interesting to see global business voices recognising an opportunity in medicines manufacturing if the new UK government gets its act together on planning.

Join us in Glasgow tomorrow

I'm in Scotland this week for our Glasgow regional event and look forward to learning more about the clinical trial capability, particularly in the West of Scotland and amongst our members. Ensuring we have a clinical trial system in the NIHR and a regulatory system around the MHRA that delivers on time and on target is a key issue many members continue to race with me. I'm keen to learn more about your experience, positive and negative, to gain a full picture of where the UK system stands in relation to international peers through 2024. It's a topic that I'm sure will be at the heart of our joint conference with the MHRA later in the year.

Women in Biotech 

Bristol welcomed Women in Biotech to town very warmly last Thursday, with the Bristol BioDesign Institute hosting the event at the university. An inspiring panel of female founders, entrepreneurs and experts spoke candidly about both the challenges and opportunities for female leadership in the Deep Biotech space and many connections were made.

Vision for life sciences

If you've heard one of my speeches at a BIA event this year, you're aware that we're in the process of updating our sector's vision for the next ten years. Back in 2015, we set out to establish the sector as the third global cluster by 2025. Now is an ideal time to review our progress and plan for the future. Your assistance is crucial. This week, we plan to survey a broad group of BIA members regarding our initial ideas, and I would greatly value your input. Keep an eye out for an email later this week.

Last chance to secure your attendance at our Summer Party - I do hope you can join us!

Event listing image Glasgow Reg 2024.png

BIA regional focus: Glasgow

Technology and Innovation Centre
Summer party 2024 - website event listing banner (002).png

BIA Summer Party 2024

The Langham Hotel, London

 

Steve Bates Headshot.png

 

 

Steve Bates OBE
CEO, BioIndustry Association

More news and updates 

Promising results from cardiac fibrosis studies with MRX1

Ananda Developments PLC, a clinical-stage life sciences company focused on the development of CBD based therapies for the treatment of a range of complex inflammatory pain conditions, is delighted to share promising results from recent preclinical studies investigating the efficacy of MRX1 (Patent Pending) in treating cardiac fibrosis and heart failure with preserved ejection fraction (HFpEF).

Valneva Scotland appoints science communications consultancy, Perceptive Communicators

Glasgow-based specialist communications consultancy, Perceptive Communicators, has announced its appointment to provide strategic communications services for Valneva Scotland.

CEO Update - 1 July 2024

I will watch the General Election this Thursday with great interest, like the rest of the country, and update you on the new ministers and members of Parliament next week. You can access the policy backgrounds of the main parties and view our webinar on what the campaign has taught us about what our sector should expect from the new parliament and government.

Shaping future leaders in biomanufacturing: insights from MAC LeaP

Over the past nine years, Dr Tony Bradshaw, Managing Director of Biosocius, has collected data from three distinct projects within the biotechnology sector. This effort has yielded unique and valuable insights that can help professionals thrive and build sustainable, fulfilling careers. By analysing behavioural profiles and consulting with industry experts, we can better understand the evolving demands of leadership in bioscience.

Coulter Partners places Head of Sales North America at Pelago Bioscience

Coulter Partners recently partnered with Pelago Bioscience and is pleased to announce the placement of Brian Jarecki, PhD as Head of Sales North America.

Discovery Park Innovation Summit showcases Kent’s ambition to be a leader in healthy ageing

Discovery Park welcomed experts in healthy ageing to its Innovation Summit on 20th June, calling for the life science network in Kent to join forces to make the county a leader in healthy ageing and longevity.

Cryoport Systems officially launches global supply chain hub in Stevenage, U.K.

Cryoport Systems' new global Supply chain hub in Stevenage will enhance the company's ability to provide comprehensive supply chain and logistics solutions for advanced therapy manufacturers in the UK and across Europe.

Why digital matters for neurodegeneration treatments

Molly Andrews of the UK Dementia Research Institute, Priya Kalia of SciTribe, and Miranda Weston-Smith of BioBeat highlight the urgent need for innovative digital solutions and investments in the accurate diagnosis and effective treatment of neurodegenerative diseases, as emphasised at BioBeat24.

Engitix appoints two additional international biotech industry leaders as Scientific Advisors

Engitix Ltd announced the appointment of two biotech industry leaders as Scientific Advisors: Adrian S. Ray, PhD, and Scott Turner, PhD.

RoslinCT appoints Professor Sir Peter Mathieson and Alexander Vos as Non-Executive Directors

RoslinCT is pleased to announce the appointment of Professor Sir Peter Mathieson MB BS (Hons), PhD, FRCP, FRCPE, FMedSci, FRSE, FRSA and Alexander Vos as new Non-Executive Directors.

CEO Update - 24 June 2024

In two Newscasts time, we will know the outcome of the UK General Election to be held on Thursday, 4 July. Join our webinar tomorrow at 1 pm where we will discuss what we have learned from the campaigns and manifestoes about potential future policies and people important for our sector after the result.

Rare Disease Community Event – meeting report

On 6 June 2024, the MRC National Mouse Genetics Network (NMGN) and the Mary Lyon Centre at MRC Harwell (MLC) hosted a Resources and Funding Opportunities in Rare Diseases event at the Advance Training Centre aimed at sharing information on resources and funding opportunities in the specific area of preclinical and clinical research and fostering new collaborative initiatives between academia, industry and advocacy/patient groups.

More within